The role of cell-associated virus in mother-to-child HIV transmission

J Infect Dis. 2014 Dec 15;210 Suppl 3(Suppl 3):S631-40. doi: 10.1093/infdis/jiu344.

Abstract

Mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) continues to contribute to the global burden of disease despite great advances in antiretroviral (ARV) treatment and prophylaxis. In this review, we discuss the proposed mechanisms of MTCT, evidence for cell-free and cell-associated transmission in different routes of MTCT, and the impact of ARVs on virus levels and transmission. Many population-based studies support a role for cell-associated virus in transmission and in vitro studies also provide some support for this mode of transmission. However, animal model studies provide proof-of-principle that cell-free virus can establish infection in infants, and studies of ARVs in HIV-infected pregnant women show a strong correlation with reduction in cell-free virus levels and protection. ARV treatment in MTCT potentially provides opportunities to better define the infectious form of virus, but these studies will require better tools to measure the infectious cell reservoir.

Keywords: HIV-1; breast milk; cell-associated virus; cell-free virus; genital secretions; infected leukocytes; mother-to-child transmission.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Anti-HIV Agents / therapeutic use
  • Breast Feeding / adverse effects
  • Female
  • HIV / drug effects
  • HIV / physiology*
  • HIV Infections / drug therapy
  • HIV Infections / transmission*
  • HIV Infections / virology
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical* / prevention & control
  • Milk, Human / virology
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Pregnancy Complications, Infectious / virology

Substances

  • Anti-HIV Agents